Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

ESMO: 10-Year Survival Data for Lung Cancer Immunotherapy, New Psma-Targeted Therapy for Recurrent Prostate Cancer, Promising Results in Metastatic Colorectal and Urothelial Cancers

Highlights include a decade of survival data from immunotherapy for advanced lung cancer, a novel PSMA-targeted radioligand therapy offering new hope for men with recurrent prostate cancer, encouraging clinical trial results in colorectal cancer and a potential new therapy for advanced bladder cancer.

October 20, 2025


October 20 2025

October 19 2025

October 18 2025

October 17 2025

October 16 2025

October 15 2025

October 14 2025

October 13 2025

October 12 2025

October 11 2025

October 10 2025

October 9 2025

October 8 2025

October 7 2025

October 6 2025